GLOBE PHARMA ApS: Financial statements 2025
CVR: 36493119
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
GLOBE PHARMA ApS (CVR 36493119) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,623,545 and a net result of DKK 460,318 compared with DKK 738,896 the year before. That is a decrease of 31.2% compared with the year before. Equity in the 2025 report amounted to DKK 511,882. The solvency ratio was 25.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,623,545
- Profit/Loss
- DKK 460,318
- Equity
- DKK 511,882
- Total Assets
- DKK 2,017,751
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.6 mio. | 460 t. | 512 t. | 1 |
| 2024 | - | 2.4 mio. | 739 t. | 790 t. | 1 |
| 2023 | - | 1.5 mio. | 458 t. | 509 t. | 1 |
| 2022 | - | 2.2 mio. | 1.1 mio. | 1.1 mio. | 1 |
| 2021 | - | 1.6 mio. | 484 t. | 535 t. | 1 |
Official annual report
How creditworthy is GLOBE PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout GLOBE PHARMA ApS
GLOBE PHARMA ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anders Ravn. The company is owned by RAVNEN HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 1,623,545 and a net result of DKK 460,318 compared with DKK 738,896 the year before. Equity in the 2025 report amounted to DKK 511,882.
